RIPERTAMAB
UNII URS0374MIV

Substance Identification & Data

This profile provides standardized clinical and technical data for Ripertamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) URS0374MIV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2249927-04-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

URS0374MIV

CAS Registry Number

2249927-04-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RIPERTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C122680

National Cancer Institute reference terminology for clinical and research data.

INN ID

11212

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ripertamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RIPERTAMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS MS4A1 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1, CD20)), CHIMERIC MONOCLONAL ANTIBODY

IMMUNOGLOBULIN IGG1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL DISULFIDE SCT400 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SCT400 .KAPPA.-CHAIN, DIMER

RIPERTAMAB [INN]

RIPERTAMAB [WHO-DD]